sahin.io

Investors

Who Invested in Latus Bio?

Latus Bio is developing curative AAV gene therapy products for CNS disorders

Company ValueNot published
MarketBiotech
Known Investors9
StatusLive

Angel Investor

Sahin Boydas

Angel Investor · 234+ companies across 37 markets

Investors in Latus Bio include Gaingels and 8VC. Of its investors, these are in the most other companies in Sahin’s portfolio.

Institutional Investors in Latus Bio

  • DCVC BioVenture Capital
  • BioAdvanceVenture Capital
  • 8VCVenture Capital
  • Ben Franklin Technology PartnersInvestment Firm
  • GaingelsVenture Capital
  • Modi VenturesInvestment Firm
  • Samsung VenturesCorporate Investor
  • Helen’s Pink Sky FoundationInvestor
  • KDB Silicon ValleyInvestment Firm

Angel Investor: Sahin Boydas

Sahin Boydas

#1 most active angel investor in the U.S. in 2024 (Lenny's Newsletter)

Companies
234+
Markets
37
$1B+ Companies
46
Biotech Companies
10

Why Angel Investors Matter for Latus Bio

Angel investors like Sahin Boydas provide more than capital to companies like Latus Bio. They bring early-stage validation, industry connections, and strategic guidance that help startups navigate from idea to product-market fit. Latus Bio is part of a broader thesis on the Biotech market, where the public portfolio holds 10 companies in total.

Angel investors typically invest at the earliest stages, when risk is highest but potential returns are greatest. Latus Bio’s progress reflects the early conviction that angel investors placed in the company's vision and team.

View the Latus Bio profile

This evidence-based directory lists investors in the sources below. It may not be complete.

Return to Latus Bio profile

Browse more investors

Other Biotech companies with investors